Morgan Stanley: Marvell’s Lumentum acquisition bets on photonic-electronic integration, but high price raises execution bar

How aggressive is the deal?

Marvell plans to acquire Lumentum in an all-stock transaction at a fixed exchange ratio of 4.5 Marvell shares for each Lumentum share. The deal implies an enterprise value of approximately 115 billion dollars, a premium of 23.9% to Lumentum’s unaffected closing price on 28 October.
The transaction is expected to close in the first half of 2028, after which existing Marvell and Lumentum shareholders will own approximately 67% and 33% of the combined company, respectively. The deal also requires approval from both companies’ shareholders and regulators in the United States and China.
The price is approximately 22 times Lumentum’s current quarterly revenue on an annualized basis. Morgan Stanley considers the deal strategically sound and says Marvell’s record with past acquisitions such as Inphi provides confidence, but the high price leaves little room for execution errors. The bank maintains its Equal-weight rating and 300-dollar price target on Marvell.

Morgan Stanley believes next-generation optical interconnects, especially scale-up architectures, require switch chips, optical engines and light sources to be co-designed along a common roadmap. Lumentum provides indium phosphide lasers, optical switching and manufacturing capabilities; Marvell provides switch chips, DSPs and custom chips. Integration could improve performance, shorten qualification times and increase product content value per connection.
The companies’ existing partnership can also deliver some technical benefits, but the acquisition can additionally secure priority access to scarce indium phosphide capacity. Lumentum’s second large NPO/CPO project is expected to begin shipping in the second half of 2027, with management expecting it to generate more than 5 billion dollars in revenue.
The companies expect annualized cost synergies to exceed 1 billion dollars by incorporating each other’s products into their existing solutions, primarily through cost of goods sold. For example, replacing third-party products in modules with in-house DSPs can capture the original suppliers’ margins. However, existing transactions between the two companies will be eliminated upon consolidation, generating no additional profit and reducing the scope for replacing external products.

Marvell supplies DSPs to module makers that compete with Lumentum. After the acquisition, these customers may worry about supplier neutrality and switch to other chip suppliers. Marvell is a leader in commercial PAM4 DSPs, so even a small loss of share would have an impact.
Management says it will continue selling components across the ecosystem. Morgan Stanley believes next-generation DSP design wins awarded by module makers during the transaction process will be an important indicator of customer relationships.
Lumentum’s margins are also currently high: in the first quarter of fiscal 2027, at an annualized revenue run rate of approximately 5 billion dollars, gross margin was 53.2% and operating margin was 42.3%, both above the target ranges it had previously set at an annualized revenue level of 8 billion dollars. If increased supply or intensifying competition erodes scarcity-driven laser profits, the deal’s valuation will come under pressure.
Manufacturing assets will also increase capital intensity: Lumentum’s capital expenditure in fiscal 2026 was approximately 15% of revenue, versus the mid-to-high single digits for Marvell. When the demand cycle weakens, the combined company will also face greater fixed-cost and working-capital risks.

The companies expect the deal to be accretive to non-GAAP earnings per share in the first year after closing. Assuming the deal closes in 2028 and using 2029 as the first full calendar year, Morgan Stanley estimates combined revenue of approximately 71 billion dollars and non-GAAP earnings per share of 20.27 dollars. Its model includes 700 million dollars in cost-of-goods-sold synergies, but excludes operating expense and revenue synergies.
The bank’s estimate of 20.27 dollars is approximately 3% above the 2029 market consensus of 19.76 dollars, but below its own forecast of 21.55 dollars in earnings per share for Marvell as a standalone company, implying slight dilution relative to the bank’s own baseline. The ultimate result depends on the operating performance of both companies, the pace of synergy realization and the closing date.